Blockade of Inflammation and Airway Hyperresponsiveness in Immune-sensitized Mice by Dominant-Negative Phosphoinositide 3-Kinase-TAT

Journal of Experimental Medicine

Volumn 198, Issue 10, 2003, Pages 1573-1582

  Myou, Shigeharu ^a   Leff, Alan R ^a   Myo, Saori ^a   Boetticher, Evan ^a   Tong, Jiankun ^a   Meliton, Angelo Y ^a   Liu, Jie ^a   Munoz, Nilda M ^a   Zhu, Xiangdong ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergy; Cytokines; Eosinophils; Inflammation; Lung

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EOSINOPHIL; EPITHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS; HYPERSENSITIVITY; INFLAMMATION; LEUKOCYTE; LUNG INFILTRATE; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MUCUS; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; SIGNAL TRANSDUCTION; TH2 CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-5; LUNG; MICE; RESPIRATORY TRACT DISEASES;

EID: 0344154290     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030298     Document Type: Article

References (51)

1. Bochner, B.S., B.J. Undem, and L.M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 12:295-335.
2. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A.J. Wardlaw, C.J. Corrigan, B. Bradley, S.R. Durham, J.V. Collins, P.K. Jeffery, et al. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
3. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A.B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
4. Weiss, J.W., J.M. Drazen, N. Coles, E.R. McFadden, Jr., P.F. Weller, E.J. Corey, R.A. Lewis, and K.F. Austen. 1982. Bronchoconstrictor effects of leukotriene C in humans. Science. 216:196-198.
5. Cuss, F.M., C.M. Dixon, and P.J. Barnes. 1986. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 2:189-192.
6. White, S.R., M.E. Strek, G.V. Kulp, S.M. Spaethe, R.A. Burch, S.P. Neeley, and A.R. Leff. 1993. Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2. J. Clin. Invest. 91:2118-2125.
7. Lefort, J., M.A. Nahori, C. Ruffie, B.B. Vargaftig, and M. Pretolani. 1996. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J. Clin. Invest. 97:1117-1121.
8. Whitman, M., C.P. Downes, M. Keeler, T. Keller, and L. Cantley. 1988. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 332:644-646.
9. Dhand, R., K. Hara, I. Hiles, B. Bax, I. Gout, G. Panayotou, M.J. Fry, K. Yonezawa, M. Kasuga, and M.D. Waterfield. 1994. PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13:511-521.
10. Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowaki, T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:875-881.
11. Fukao, T., T. Yamada, M. Tanabe, Y. Terauchi, T. Ota, T. Takayama, T. Asano, T. Takeuchi, T. Kadowaki, J. Hata Ji, and S. Koyasu. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3:295-304.
12. Palframan, R.T., P.D. Collins, N.J. Severs, S. Rothery, T.J. Williams, and S.M. Rankin. 1998. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J. Exp. Med. 188:1621-1632.
13. Dunzendorfer, S., C. Meierhofer, and C.J. Wiedermann. 1998. Signaling in neuropeptide-induced migration of human eosinophils. J. Leukoc. Biol. 64:828-834.
14. Krymskaya, V.P., R.B. Penn, M.J. Orsini, P.H. Scott, R.J. Plevin, T.R. Walker, A.J. Eszterhas, Y. Amrani, E.R. Chilvers, and R.A. Panettieri, Jr. 1999. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. Am. J. Physiol. 277:L65-L78.
15. Smith, A.J., Z. Surviladze, E.A. Gaudet, J.M. Backer, C.A. Mitchell, and B.S. Wilson. 2001. p110β and p110delta phosphatidylinositol 3-kinases up-regulate Fc(epsilon)RI-activated Ca2+ influx by enhancing inositol 1,4,5-trisphosphate production. J. Biol. Chem. 276:17213-17220.
16. Page, K., J. Li, J.A. Hodge, P.T. Liu, T.L. Vanden Hoek, L.B. Becker, R.G. Pestell, M.R. Rosner, and M.B. Hershenson. 1999. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J. Biol. Chem. 274:22065-22071.
17. Bracke, M., E. van de Graaf, J.W. Lammers, P.J. Coffer, and L. Koenderman. 2000. In vivo priming of FcαR, functioning on eosinophils of allergic asthmatics. J. Leukoc. Biol. 68:655-661.
18. Fruman, D.A., F. Mauvais-Jarvis, D.A. Pollard, C.M. Yballe, D. Brazil, R.T. Bronson, C.R. Kahn, and L.C. Cantley. 2000. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85α. Nat. Genet. 26:379-382.
19. Fruman, D.A., S.B. Snapper, C.M. Yballe, L. Davidson, J.Y. Yu, F.W. Alt, and L.C. Cantley. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science. 283:393-397.
20. Schwarze, S.R., A. Ho, A. Vocero-Akbani, and S.F. Dowdy. 1999. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1569-1572.
21. Kotani, K., K. Yonezawa, K. Hara, H. Ueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, F. Grigorescu, et al. 1994. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:2313-2321.
22. Nagahara, H., A.M. Vocero-Akbani, E.L. Snyder, A. Ho, D.G. Latham, N.A. Lissy, M. Becker-Hapak, S.A. Ezhevsky, and S.F. Dowdy. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4:1449-1452.
23. Myou, S., X. Zhu, E. Boetticher, S. Myo, A. Meliton, A. Lambertino, N.M. Munoz, and A.B. Leff. 2002. Blockade of focal clustering and active conformation in β2-integrin-mediated adhesion of eosinophils to intercellular adhesion molecule-1 caused by transduction of HIV TAT-dominant negative Ras. J. Immunol. 169:2670-2676.
24. Hall, D.J., J. Cui, M.E. Bates, B.A. Stout, L. Koenderman, P.J. Coffer, and P.J. Bertics. 2001. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood. 98:2014-2021.
25. Mathur, M., K. Herrmann, X. Li, Y. Qin, J. Weinstock, D. Elliott, J. Monahan, and P. Padrid. 1999. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am. J. Respir. Crit. Care Med. 159:580-587.
26. Humbles, A.A., B. Lu, C.A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N.P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature. 406:998-1001.
27. Duguet, A., K. Biyah, E. Minshall, R. Gomes, C.G. Wang, M. Taoudi-Benchekroun, J.H. Bates, and D.H. Eidelman. 2000. Bronchial responsiveness among inbred mouse strains. Role of airway smooth-muscle shortening velocity. Am. J. Respir. Crit. Care Med. 161:839-848.
28. Ford, J.G., D. Rennick, D.D. Donaldson, R. Venkayya, C. McArthur, E. Hansell, V.P. Kurup, M. Warnock, and G. Grunig. 2001. Il-13 and IFN-γ: interactions in lung inflammation. J. Immunol. 167:1769-1777.
29. Hsieh, C.S., A.B. Heimberger, J.S. Gold, A. O'Garra, and K.M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an α β T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:6065-6069.
30. Seder, R.A., W.E. Paul, M.M. Davis, and B. Fazekas de St Groth. 1992. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.
31. Coffman, R.L., J. Ohara, M.W. Bond, J. Carty, A. Zlotnik, and W.E. Paul. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136:4538-4541.
32. Pawankar, R., M. Okuda, H. Yssel, K. Okumura, and C. Ra. 1997. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1492-1499.
33. Moser, R., J. Fehr, and P.L. Bruijnzeel. 1992. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149:1432-1438.
34. Dabbagh, K., K. Takeyama, H.M. Lee, I.F. Ueki, J.A. Lausier, and J.A. Nadel. 1999. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol. 162:6233-6237.
35. Mauser, P.J., A.M. Pitman, X. Fernandez, S.K. Foran, G.K. Adams, III, W. Kreutner, R.W. Egan, and R.W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467-472.
36. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
37. Rabe, K.F., N.M. Munoz, A.J. Vita, B.E. Morton, H. Magnussen, and A.R. Leff. 1994. Contraction of human bronchial smooth muscle caused by activated human eosinophils. Am. J. Physiol. 267:L326-L334.
38. Strek, M.E., F.S. Williams, G.J. Gleich, A.R. Leff, and S.R. White. 1996. Mechanisms of smooth muscle contraction elicited by cationic proteins in guinea pig trachealis. Am. J. Physiol. 270:L133-L140.
39. Zhu, X., B. Jacobs, E. Boetticher, S. Myou, A. Meliton, H. Sano, A.T. Lambertino, N.M. Munoz, and A.R. Leff. 2002. IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2. J. Leukoc. Biol. 72:1046-1053.
40. Kwak, Y.G., C.H. Song, H.K. Yi, P.H. Hwang, J.S. Kim, K.S. Lee, and Y.C. Lee. 2003. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111:1083-1092.
41. Ezeamuzie, C.I., J. Sukumaran, and E. Philips. 2001. Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in Guinea pigs in vivo. Am. J. Respir. Crit. Care Med. 164:1633-1639.
42. Sasaki, T., J. Irie-Sasaki, R.G. Jones, A.J. Oliveira-dos-Santos, W.L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al. 2000. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science. 287:1040-1046.
43. Powell, N., S. Till, J. Bungre, and C. Corrigan. 2001. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients. J. Allergy Clin. Immunol. 108:915-917.
44. Fujitani, Y., and A. Trifilieff. 2003. In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am. J. Respir. Crit. Care Med. 167:193-198.
45. Vachier, I., P. Chanez, T. Radeau, C. Le Doucen, C. Leger, and P. Godard. 1997. Cellular protein kinase C activity in asthma. Am. J. Respir. Crit. Care. Med. 155:1211-1216.
46. Le Good, J.A., W.H. Ziegler, D.B. Parekh, D.R. Alessi, P. Cohen, and P.J. Parker. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 281:2042-2045.
47. Chou, M.M., W. Hou, J. Johnson, L.K. Graham, M.H. Lee, C.S. Chen, A.C. Newton, B.S. Schaffhausen, and A. Toker. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 8:1069-1077.
48. Evans, D.J., M.A. Lindsay, B.L. Webb, H. Kankaanranta, M.A. Giembycz, B.J. O'Connor, and P.J. Barnes. 1999. Expression and activation of protein kinase C-zeta in eosinophils after allergen challenge. Am. J. Physiol. 277:L233-L239.
49. Cross, M.J., A. Stewart, M.N. Hodgkin, D.J. Kerr, and M.J. Wakelam. 1995. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 270:25352-25355.
50. Bonser, R.W., N.T. Thompson, R.W. Randall, J.E. Tateson, G.D. Spacey, H.F. Hodson, and L.G. Garland. 1991. Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br. J. Pharmacol. 103:1237-1241.
51. Arcaro, A., and M.P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297-301.